Scholarlink

<p>The Melbourne Epidemiological Study of Childhood Asthma (MESCA) is one of the longest-running respiratory studies in the world. The study aimed to determine the prevalence and describe the natural history of childhood asthma and wheezy bronchitis. MESCA started in 1964, when four asthma/wheeze groups and a control group, all aged 7, were recruited and have been followed into their seventh decade. The study has collected unique, repeated data on asthma, respiratory symptoms, and lung function over seven decades. It has provided critical insights into the natural history and long-term outcomes of childhood asthma. MESCA is the first prospective study to provide robust evidence for the link between childhood asthma and the development of COPD. Participants are now entering their seventh decade of life, and their rich, lifetime data provides a unique opportunity to investigate a wide range of outcomes, including multimorbidity and healthy aging.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Melbourne Epidemiological Study of Childhood Asthma (MESCA)

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月18日

查看全文
  • Dinh S Bui,
  • Andrew Tai,
  • Jiacheng Liu,
  • Jennifer L Perret,
  • Caroline J Lodge,
  • Nur Sabrina Idrose,
  • Mary Roberts,
  • Colin Robertson,
  • Shyamali C Dharmage

摘要

The Melbourne Epidemiological Study of Childhood Asthma (MESCA) is one of the longest-running respiratory studies in the world. The study aimed to determine the prevalence and describe the natural history of childhood asthma and wheezy bronchitis. MESCA started in 1964, when four asthma/wheeze groups and a control group, all aged 7, were recruited and have been followed into their seventh decade. The study has collected unique, repeated data on asthma, respiratory symptoms, and lung function over seven decades. It has provided critical insights into the natural history and long-term outcomes of childhood asthma. MESCA is the first prospective study to provide robust evidence for the link between childhood asthma and the development of COPD. Participants are now entering their seventh decade of life, and their rich, lifetime data provides a unique opportunity to investigate a wide range of outcomes, including multimorbidity and healthy aging.